Verismo Therapeutics

PA - Philadelphia

Biotechnology

Focus: Cell Therapy

Verismo Therapeutics is a life sciences company focused on Cell Therapy.

Gene TherapyCell Therapy

Open Jobs

Pipeline & Clinical Trials

SynKIR-110

N/A

Clinical Trials (1)

NCT06701201A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

N/A

Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies

N/A

Clinical Trials (1)

NCT06377202Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies

N/A

SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR

Phase 1

Clinical Trials (1)

NCT05568680SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Phase 1

SynKIR-310

Phase 1

Clinical Trials (1)

NCT06544265SynKIR-310 for Relapsed/Refractory B-NHL

Phase 1

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 4 clinical trials